Dr. (Mrs.) Renuka Datla v. Solvay Pharmaceutical B.V. And Others

Factual and Procedural Background

The opinion records that various counsel began presenting their arguments on 12 December 2001. Mr. Shanti Bhushan argued from 11:45 a.m. to 2:30 p.m., followed by brief submissions from Mr. G. L. Sanghi and Mr. Anil B. Divan. Mr. K. K. Venugopal started his arguments at 2:50 p.m. but had not finished when the Court turned to other mentioning matters. Because the substantive arguments remained incomplete, the matters were treated as part-heard and scheduled for a future date.

Legal Issues Presented

The opinion addresses a procedural matter and does not frame distinct legal issues.

Arguments of the Parties

The opinion does not contain a detailed account of the parties' legal arguments.

Table of Precedents Cited

No precedents were cited in the provided opinion.

Court's Reasoning and Analysis

The Court noted that oral arguments had not concluded and therefore treated the matters as part-heard. To allow completion of those arguments, the bench adjourned the case and fixed 8 January 2002 for further hearing. No additional substantive analysis or determination was provided.

Holding and Implications

ADJOURNED – The matters are to be listed on 8 January 2002 before the same bench as part-heard for completion of arguments.

Implications: The decision simply reschedules the hearing; it has no broader legal impact and sets no new precedent.